You are here: Home > Optometry Australia Institute of Excellence > Calendar > CPD Events > PHARMA – June 2019

PHARMA - June 2019

Provider: OA National Provider

Contact: Optometry Australia OA Provider, [E] s.hanna@optometry.org.au, [P] 96688550

Learning Objectives

  • gain an understanding on the functional vision loss experienced by patients with ring scotomas due to AMD and how to manage such patients
  • become more familiar with the various peripheral retinal changes that occur in AMD and how these can be detected
  • become more familiar with the ocular conditions optometrists usually experience and challenges faced in domiciliary eye care
  • become more familiar with the factors associated with anti-VEGF therapy in the treatment of neovascular AMD
  • gain an understanding of the clinical classification of AMD
  • become more familiar with the evidence-based modifiable lifestyle risk factors associated with AMD
  • become more familiar with the LEAD trial and the potential role of nanosecond laser treatment for AMD
  • become more familiar with the use of OCT in the investigation of various systemic neurologic disease
  • gain an understanding of how to differentiate macular dystrophies from AMD
  • gain an understanding of the support and services provided by low vision providers and when it may be appropriate to refer patients to such providers

Max points awarded: 6.00

Session Information

Name
PHARMA - June 2019
Activity Type
Independent Learning with Assessment
Therapeutic?
No
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
5.00
Name
PHARMA - June 2019
Activity Type
Independent Learning with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
1.00

NameActivity TypeTherapeutic?Manufacturer/
Supplier?
Points for attending &
Passing Assessment
PHARMA - June 2019Independent Learning with AssessmentNoNo5.00
PHARMA - June 2019Independent Learning with AssessmentYesNo1.00